Rubric Capital Management LP Collegium Pharmaceutical, Inc Transaction History

Rubric Capital Management LP

  • $3.49 Billion
  • Q1 2025

A detailed history of Rubric Capital Management LP transactions in Collegium Pharmaceutical, Inc stock. As of the latest transaction made, Rubric Capital Management LP holds 3,000,000 shares of COLL stock, worth $92.7 Million. This represents 2.57% of its overall portfolio holdings.

Number of Shares
3,000,000
Previous 2,350,000 27.66%
Holding current value
$92.7 Million
Previous $67.3 Million 33.01%
% of portfolio
2.57%
Previous 1.11%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 14, 2025
BUY
$28.04 - $33.91 $18.2 Million - $22 Million
650,000 Added 27.66%
3,000,000 $89.6 Million
Q4 2024

Feb 14, 2025
BUY
$28.61 - $41.86 $31.5 Million - $46 Million
1,100,000 Added 88.0%
2,350,000 $67.3 Million
Q3 2024

Nov 13, 2024
SELL
$31.4 - $39.07 $34 Million - $42.3 Million
-1,083,500 Reduced 46.43%
1,250,000 $48.3 Million
Q2 2024

Aug 13, 2024
BUY
$31.36 - $39.99 $15.7 Million - $20 Million
499,473 Added 27.23%
2,333,500 $75.1 Million
Q1 2024

May 10, 2024
SELL
$31.23 - $40.91 $28.9 Million - $37.8 Million
-924,226 Reduced 33.51%
1,834,027 $71.2 Million
Q4 2023

Feb 13, 2024
SELL
$21.16 - $30.8 $8.82 Million - $12.8 Million
-416,747 Reduced 13.13%
2,758,253 $84.9 Million
Q3 2023

Nov 14, 2023
SELL
$21.23 - $24.28 $5.31 Million - $6.07 Million
-250,000 Reduced 7.3%
3,175,000 $71 Million
Q2 2023

Aug 11, 2023
BUY
$21.06 - $24.0 $3.18 Million - $3.62 Million
150,832 Added 4.61%
3,425,000 $73.6 Million
Q1 2023

May 12, 2023
SELL
$23.0 - $29.88 $1.37 Million - $1.78 Million
-59,460 Reduced 1.78%
3,274,168 $78.5 Million
Q3 2022

Nov 14, 2022
BUY
$15.46 - $20.1 $1.16 Million - $1.51 Million
75,000 Added 2.3%
3,333,628 $53.4 Million
Q2 2022

Aug 15, 2022
BUY
$14.22 - $20.88 $3.68 Million - $5.4 Million
258,628 Added 8.62%
3,258,628 $57.7 Million
Q1 2022

May 13, 2022
BUY
$17.2 - $22.5 $6.77 Million - $8.85 Million
393,500 Added 15.1%
3,000,000 $61.1 Million
Q3 2021

Nov 12, 2021
BUY
$17.75 - $25.39 $3.31 Million - $4.73 Million
186,286 Added 7.7%
2,606,500 $51.5 Million
Q1 2021

May 14, 2021
BUY
$19.25 - $26.1 $9.51 Million - $12.9 Million
493,931 Added 25.64%
2,420,214 $57.4 Million
Q2 2020

Aug 10, 2020
BUY
$15.49 - $23.51 $11 Million - $16.8 Million
712,871 Added 58.75%
1,926,283 $33.7 Million
Q1 2020

May 14, 2020
BUY
$13.89 - $25.45 $16.9 Million - $30.9 Million
1,213,412 New
1,213,412 $19.8 Million

Others Institutions Holding COLL

# of Institutions
253
Shares Held
37.1M
Call Options Held
61.1K
Put Options Held
5.8K
View Full List

About COLLEGIUM PHARMACEUTICAL, INC

COLL Quotes by TradingView
  • Ticker COLL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 34,126,200
  • Market Cap $1.05B
  • Description
  • Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol; and Xtampza ...
More about COLL
Track This Portfolio

Track Rubric Capital Management LP Portfolio

Follow Rubric Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rubric Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Rubric Capital Management LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email